Within the TGFβ pathway, loss of function mutations are most common, particularly in gastrointestinal cancers [91], notably in pancreatic cancers and colorectal cancers (up to 100% and 83% of patients respectively) [92,93]. The gene discussed is TGFB1; the disease is pancreatic neoplasm.